comparemela.com

Latest Breaking News On - Director rajiv vinnakota - Page 8 : comparemela.com

7,203 Shares in Enovis Co (NYSE:ENOV) Acquired by First Light Asset Management LLC

First Light Asset Management LLC acquired a new position in shares of Enovis Co. (NYSE:ENOV – Get Rating) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 7,203 shares of the company’s stock, valued at approximately $386,000. Other institutional investors have also recently modified their holdings of […]

Enovis Co (NYSE:ENOV) Sees Large Decline in Short Interest

Enovis Co. (NYSE:ENOV – Get Rating) was the recipient of a significant decrease in short interest in May. As of May 15th, there was short interest totalling 1,810,000 shares, a decrease of 6.7% from the April 30th total of 1,940,000 shares. Approximately 3.7% of the company’s stock are sold short. Based on an average daily […]

Harpoon Therapeutics, Inc (NASDAQ:HARP) Given Average Rating of Moderate Buy by Brokerages

Shares of Enovis Co. (NYSE:ENOV – Get Rating) have been assigned a consensus recommendation of “Moderate Buy” from the ten analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 12 month price […]

Enovis (NYSE:ENOV) Upgraded to Overweight at Wells Fargo & Company

Wells Fargo & Company upgraded shares of Enovis (NYSE:ENOV – Get Rating) from an equal weight rating to an overweight rating in a report issued on Friday, The Fly reports. The brokerage currently has $67.00 price target on the stock, up from their previous price target of $55.00. Several other equities research analysts have also […]

Wells Fargo & Company Upgrades Enovis (NYSE:ENOV) to Overweight

Wells Fargo & Company upgraded shares of Enovis (NYSE:ENOV – Get Rating) from an equal weight rating to an overweight rating in a research report report published on Friday morning, The Fly reports. Wells Fargo & Company currently has $67.00 price target on the stock, up from their previous price target of $55.00. Other research […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.